NCT06861426Not yet recruiting
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
Patients with Acute Ischemic Stroke Receiving Ginkgo Diterpene Lactone Meglumine: a Patient Registry
Source: ClinicalTrials.gov · Last updated 6 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary purpose of this study is to investigate the effectiveness of Ginkgo Diterpene Lactone Meglumine (GDLM) for patients with acute ischemic stroke (AIS) in real-world settings.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 4460 (estimated)
- First submitted
- 27 Feb 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Ying Gao
- Diseases
- Stroke
- NCT number
- NCT06861426
What you commit to
- Study type: Observational
- Planned participants: 4460
- From 1 Mar 2025 to the primary completion date, 30 Sept 2025
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- mRS score of 2 or more prior to onset
Other illness
- inability to comply with study procedures due to documented psychiatric disorders or severe cognitive impairment
Other
- total hospital stay less than 7 days
- use of other ginkgo-derived preparations except GDLM
- current or planned participation in any other interventional clinical trials
Who the study is looking for
- aged ≥18 years, regardless of gender
- within 48 hours of stroke onset of ischemic stroke
- patient or their legally authorized representative (LAR) has signed informed consent or legally authorized oral consent with documentation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Hospital of Jilin University Coordinator of this site? Confirm its status | Changchun | China | Unknown status |
| Harbin Second Hospital Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
| The Fourth Affiliated Hospital of Harbin Medical University Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
| Affiliated Hospital of Jining Medical University Coordinator of this site? Confirm its status | Jining | China | Unknown status |
| Gansu Provincial People's Hospital Coordinator of this site? Confirm its status | Lanzhou | China | Unknown status |
| Jiangsu Provincial Hospital of Traditional Chinese Medicine Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
| Jiangsu Geriatric Hospital Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
| Xian Changan District Hospital Coordinator of this site? Confirm its status | Xian | China | Unknown status |
| Xuzhou Hospital of Traditional Chinese Medicine Coordinator of this site? Confirm its status | Xuzhou | China | Unknown status |
| Henan Provincial People's Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.